<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01482598</url>
  </required_header>
  <id_info>
    <org_study_id>CR‐11‐017‐IT‐HF</org_study_id>
    <nct_id>NCT01482598</nct_id>
  </id_info>
  <brief_title>Clinical Benefits in Optimized Remote HF Patient Management</brief_title>
  <acronym>COR-HF</acronym>
  <official_title>COR HF - Clinical Benefits in Optimized Remote HF Patient Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Study Purpose is to demonstrate the superiority of optimized remote patient management
      compared to optimized standard care in the management and prognosis of heart failure, in the
      prevention of recurrent atrial tachycardia or atrial fibrillation episodes and in the
      reduction of inappropriate shock therapies. The remote care allows early intervention in
      terms of drug therapy adjustment and cardiac resynchronization therapy (CRT‐D) device
      reprogramming.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The outcome measure of the study is a combined endpoint of:

        -  Proportion of patients with HF hospitalization or emergency unit admission with
           intravenous diuretics, Atrial Tachycardia/Atrial Fibrillation (AT/AF) episodes or
           cardiovascular/cerebrovascular episodes requiring hospitalization at 12 months

        -  Proportion of patients with inappropriate Implantable Cardioverter-Defibrillator (ICD)
           therapies delivered at 12 months comparing optimized remote patient management to
           optimized standard patient management
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Combined Endpoint on patient clinical outcome</measure>
    <time_frame>12 months follow up</time_frame>
    <description>Combined Endpoint:
proportion of patients with HF hospitalization or emergency unit admission with intravenous diuretics, AT/AF episodes or cardiovascular/cerebrovascular episodes requiring hospitalization at 12 months
proportion of patients with inappropriate ICD therapies delivered at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy and safety of CRT in remote care pts</measure>
    <time_frame>12 and 24 months follow up</time_frame>
    <description>Proportion of patients with additional unscheduled clinic fups at 24 months
% biventricular pacing at 12 and 24 months
LVESV reduction &gt;15% at 12 months
Time to first clinical event
Time from onset of the event to the clinical intervention
Mortality at 24 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">438</enrollment>
  <condition>Congestive Heart Failure Treated</condition>
  <arm_group>
    <arm_group_label>Optimal Remote Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient follow up is performed through remote care, remote alerts on CRT-D device data are transmitted daily to the hospital, remote follow up is scheduled every 6 months, hospital in clinic follow up is scheduled at 12 months after implant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient standard in clinic visits are performed every 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remote Care Follow up</intervention_name>
    <description>Patient device is checked daily through remote transmitter (Merlin@Home) and every 6 month a complete transmission with all device data is performed</description>
    <arm_group_label>Optimal Remote Care</arm_group_label>
    <other_name>Home monitoring, Remote monitoring, Merlin.net</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart failure patients already implanted with CRT‐D devices (from 4 to 8 weeks),
             according to current guidelines1

          -  1 hospitalization or access to emergency unit due to heart failure (including
             treatment with diuretic and/or cardioactive intravenous therapy) within the last 12
             months

          -  Left Bundle Branch Block (LBBB)

          -  Patients must be able to provide written informed consent

          -  Patients are mentally capable to participate in the Investigation (based on
             physician's discretion)

        Exclusion Criteria:

          -  Patients already implanted with CRT or CRT‐D device to be replaced

          -  Patients in long‐standing persistent or permanent AT/AF

          -  Patients in dialysis treatment at the time of enrollment

          -  Patients in parenteral inotropic therapy at the time of enrollment

          -  Patients with epicardial Left Ventricular (LV) lead

          -  Patients with mechanical valvular prosthesis

          -  Patients with life expectancy &lt; 12 months

          -  Patients actively considered for cardiac transplant

          -  Patients &lt; 18 years old

          -  Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luigi Padeletti, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Azienda Ospedaliero Universitaria Careggi, Firenze</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Grazia Bongiorni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale S.Chiara-Cisanello, Pisa</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerardo Ansalone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Vannini, Roma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gianluca Botto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale S. Anna, Como</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Curnis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spedali Civili, Brescia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano Favale, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Policlinico Consorziale, Bari</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edoardo Gronda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Multimedica IRCCS, Milano</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roberto Verlato, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Pietro Cosma, Camposampiero (PD)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandro Proclemer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale S.M. della Misericordia, Udine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luca Santini, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rome Tor Vergata</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandro Capucci, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero, Universitaria Ospedali Riuniti</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Solimene, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Casa di Cura &quot;Montevergine&quot;, Mercogliano (AV)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Casa di Cura &quot;Montevergine&quot;</name>
      <address>
        <city>Mercogliano</city>
        <state>Avellino</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Pietro Cosma</name>
      <address>
        <city>Camposampiero</city>
        <state>Padova</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osp. S.Raffaele Giglio</name>
      <address>
        <city>Cefalù</city>
        <state>Palermo</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Riunito di Ciriè</name>
      <address>
        <city>Ciriè</city>
        <state>Torino</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero di Conegliano</name>
      <address>
        <city>Conegliano</city>
        <state>Treviso</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa di Cura Pederzoli</name>
      <address>
        <city>Peschiera del Garda</city>
        <state>Verona</state>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria &quot;Ospedali Riuniti&quot;</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Consorziale</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spedali Civili</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Ferrarotto Vittorio Emanuele</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Anna</name>
      <address>
        <city>Como</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera dei Colli - Ospedale Monaldi</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Guglielmo da Saliceto</name>
      <address>
        <city>Piacenza</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Chiara - Cisanello</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Vannini</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico Tor Vergata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Belcolle</name>
      <address>
        <city>Viterbo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Santini M, Ricci RP, Lunati M, Landolina M, Perego GB, Marzegalli M, Schirru M, Belvito C, Brambilla R, Guenzati G, Gilardi S, Valsecchi S. Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. J Interv Card Electrophysiol. 2009 Jan;24(1):53-61. doi: 10.1007/s10840-008-9321-3. Epub 2008 Oct 31.</citation>
    <PMID>18975066</PMID>
  </reference>
  <reference>
    <citation>Marzegalli M, Lunati M, Landolina M, Perego GB, Ricci RP, Guenzati G, Schirru M, Belvito C, Brambilla R, Masella C, Di Stasi F, Valsecchi S, Santini M. Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation--ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol. 2008 Oct;31(10):1259-64. doi: 10.1111/j.1540-8159.2008.01175.x.</citation>
    <PMID>18811805</PMID>
  </reference>
  <reference>
    <citation>Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA; FAST Study Investigators. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 2011 Mar-Apr;17(2):51-5. doi: 10.1111/j.1751-7133.2011.00220.x. Epub 2011 Mar 21.</citation>
    <PMID>21449992</PMID>
  </reference>
  <reference>
    <citation>Abraham WT, Gras D, Yu CM, Guzzo L, Gupta MS; FREEDOM Steering Committee. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. Am Heart J. 2010 Jun;159(6):944-948.e1. doi: 10.1016/j.ahj.2010.02.034. Review.</citation>
    <PMID>20569704</PMID>
  </reference>
  <reference>
    <citation>Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Engl J Med. 2010 Dec 9;363(24):2301-9. doi: 10.1056/NEJMoa1010029. Epub 2010 Nov 16. Erratum in: N Engl J Med. 2011 Feb 3;364(5):490. N Engl J Med. 2013 Nov 7;369(19):1869.</citation>
    <PMID>21080835</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2011</study_first_submitted>
  <study_first_submitted_qc>November 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2011</study_first_posted>
  <last_update_submitted>March 3, 2016</last_update_submitted>
  <last_update_submitted_qc>March 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>Remote Care</keyword>
  <keyword>Disease Management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

